vs
Side-by-side financial comparison of Hyperfine, Inc. (HYPR) and Marygold Companies, Inc. (MGLD). Click either name above to swap in a different company.
Marygold Companies, Inc. is the larger business by last-quarter revenue ($7.6M vs $5.3M, roughly 1.4× Hyperfine, Inc.). Marygold Companies, Inc. runs the higher net margin — -7.5% vs -111.7%, a 104.2% gap on every dollar of revenue. On growth, Hyperfine, Inc. posted the faster year-over-year revenue change (128.0% vs -4.5%). Over the past eight quarters, Hyperfine, Inc.'s revenue compounded faster (26.7% CAGR vs -1.5%).
Hyperfine, Inc. develops and commercializes innovative portable low-field magnetic resonance imaging (MRI) systems for medical diagnostic use. Its solutions deliver accessible, cost-effective imaging for healthcare providers across acute care, rural clinics, pediatric care, and other underserved clinical settings worldwide.
Marygold Companies, Inc. is a U.S.-headquartered diversified holding company that operates across three core segments: financial services, specialty manufacturing, and consumer goods. It primarily caters to North American markets, driving long-term value growth via strategic investment in, and operational optimization of, its portfolio of subsidiary entities.
HYPR vs MGLD — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | ||
|---|---|---|
| Revenue | $5.3M | $7.6M |
| Net Profit | $-5.9M | $-576.0K |
| Gross Margin | 50.9% | 74.0% |
| Operating Margin | -144.9% | -8.3% |
| Net Margin | -111.7% | -7.5% |
| Revenue YoY | 128.0% | -4.5% |
| Net Profit YoY | 43.1% | 67.0% |
| EPS (diluted) | $-0.05 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.3M | $7.6M | ||
| Q3 25 | $3.4M | $7.0M | ||
| Q2 25 | $2.7M | $7.2M | ||
| Q1 25 | $2.1M | $7.0M | ||
| Q4 24 | $2.3M | $8.0M | ||
| Q3 24 | $3.6M | $7.9M | ||
| Q2 24 | $3.6M | $8.3M | ||
| Q1 24 | $3.3M | $7.9M |
| Q4 25 | $-5.9M | $-576.0K | ||
| Q3 25 | $-11.0M | $-356.0K | ||
| Q2 25 | $-9.2M | $-1.5M | ||
| Q1 25 | $-9.4M | $-1.0M | ||
| Q4 24 | $-10.4M | $-1.7M | ||
| Q3 24 | $-10.3M | $-1.6M | ||
| Q2 24 | $-10.2M | $-1.9M | ||
| Q1 24 | $-9.8M | $-529.0K |
| Q4 25 | 50.9% | 74.0% | ||
| Q3 25 | 53.8% | 77.0% | ||
| Q2 25 | 49.3% | 67.8% | ||
| Q1 25 | 41.3% | 75.0% | ||
| Q4 24 | 35.6% | 74.1% | ||
| Q3 24 | 52.4% | 73.1% | ||
| Q2 24 | 49.7% | 72.5% | ||
| Q1 24 | 41.1% | 70.5% |
| Q4 25 | -144.9% | -8.3% | ||
| Q3 25 | -259.5% | -18.2% | ||
| Q2 25 | -355.9% | -16.5% | ||
| Q1 25 | -510.2% | -21.4% | ||
| Q4 24 | -463.8% | -22.8% | ||
| Q3 24 | -300.9% | -27.4% | ||
| Q2 24 | -298.7% | -33.3% | ||
| Q1 24 | -323.2% | -18.7% |
| Q4 25 | -111.7% | -7.5% | ||
| Q3 25 | -320.6% | -5.1% | ||
| Q2 25 | -342.2% | -20.4% | ||
| Q1 25 | -440.7% | -14.4% | ||
| Q4 24 | -447.7% | -21.8% | ||
| Q3 24 | -283.4% | -20.1% | ||
| Q2 24 | -279.7% | -22.5% | ||
| Q1 24 | -298.9% | -6.7% |
| Q4 25 | $-0.05 | $-0.01 | ||
| Q3 25 | $-0.14 | $-0.01 | ||
| Q2 25 | $-0.12 | $-0.04 | ||
| Q1 25 | $-0.12 | $-0.02 | ||
| Q4 24 | $-0.14 | $-0.04 | ||
| Q3 24 | $-0.14 | $-0.04 | ||
| Q2 24 | $-0.14 | $-0.05 | ||
| Q1 24 | $-0.14 | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $35.1M | $11.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $41.0M | $22.7M |
| Total Assets | $55.3M | $27.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $35.1M | $11.6M | ||
| Q3 25 | $21.6M | $12.5M | ||
| Q2 25 | $25.4M | $12.8M | ||
| Q1 25 | $33.1M | $15.6M | ||
| Q4 24 | $37.6M | $14.9M | ||
| Q3 24 | $45.8M | $17.5M | ||
| Q2 24 | $53.8M | $15.0M | ||
| Q1 24 | $63.2M | $16.1M |
| Q4 25 | $41.0M | $22.7M | ||
| Q3 25 | $26.9M | $22.9M | ||
| Q2 25 | $35.1M | $23.0M | ||
| Q1 25 | $43.1M | $24.3M | ||
| Q4 24 | $49.0M | $23.4M | ||
| Q3 24 | $58.3M | $25.5M | ||
| Q2 24 | $66.8M | $26.6M | ||
| Q1 24 | $75.6M | $28.4M |
| Q4 25 | $55.3M | $27.8M | ||
| Q3 25 | $41.5M | $28.4M | ||
| Q2 25 | $45.2M | $30.4M | ||
| Q1 25 | $53.4M | $33.5M | ||
| Q4 24 | $58.9M | $33.0M | ||
| Q3 24 | $69.4M | $35.9M | ||
| Q2 24 | $76.6M | $32.9M | ||
| Q1 24 | $85.4M | $33.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-5.2M | $-908.0K |
| Free Cash FlowOCF − Capex | $-5.3M | — |
| FCF MarginFCF / Revenue | -99.6% | — |
| Capex IntensityCapex / Revenue | 1.2% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-29.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.2M | $-908.0K | ||
| Q3 25 | $-5.6M | $-533.0K | ||
| Q2 25 | $-7.9M | $-3.3M | ||
| Q1 25 | $-9.2M | $-1.2M | ||
| Q4 24 | $-8.4M | $-770.0K | ||
| Q3 24 | $-8.5M | $-893.0K | ||
| Q2 24 | $-9.4M | $-1.9M | ||
| Q1 24 | $-12.5M | $-658.0K |
| Q4 25 | $-5.3M | — | ||
| Q3 25 | $-5.7M | $-562.0K | ||
| Q2 25 | $-8.4M | $-3.4M | ||
| Q1 25 | $-9.7M | — | ||
| Q4 24 | $-8.4M | $-776.0K | ||
| Q3 24 | $-8.7M | $-940.0K | ||
| Q2 24 | $-9.5M | $-2.0M | ||
| Q1 24 | $-12.7M | — |
| Q4 25 | -99.6% | — | ||
| Q3 25 | -166.2% | -8.1% | ||
| Q2 25 | -312.7% | -46.8% | ||
| Q1 25 | -454.9% | — | ||
| Q4 24 | -360.4% | -9.7% | ||
| Q3 24 | -238.2% | -11.9% | ||
| Q2 24 | -260.4% | -23.8% | ||
| Q1 24 | -384.1% | — |
| Q4 25 | 1.2% | 0.0% | ||
| Q3 25 | 3.8% | 0.4% | ||
| Q2 25 | 19.3% | 0.7% | ||
| Q1 25 | 22.1% | 0.0% | ||
| Q4 24 | 0.3% | 0.1% | ||
| Q3 24 | 4.4% | 0.6% | ||
| Q2 24 | 2.0% | 0.7% | ||
| Q1 24 | 4.4% | 0.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HYPR
| Products | $4.9M | 92% |
| Other | $436.0K | 8% |
MGLD
| Fund Management Related Party | $4.6M | 60% |
| Food Products | $1.7M | 22% |
| Beauty Products | $1.2M | 15% |
| Other | $268.0K | 4% |